Skribe Medical advances wearable heart monitoring for cancer patients following selection for FDA innovation program

<p>SAN FRANCISCO, Nov. 11, 2026 /PRNewswire/ -- Skribe Medical, a U.S. medical technology company developing wearable cardiac monitoring for cancer care, today announced progress in its clinical development program following selection of its Aurora System for the U.S. Food and Drug...</p>